Search results
C. Thomas Paschall is known for The Command (2018), Gnome Alone (2017) and Charming (2018).
- Producer
- C. Thomas Paschall
Dec 8, 2021 · KT Senior EVP and Head of AI/DX Jae-ho Song and NeuroSigma Director, C. Thomas Paschall execute investment documents at KT’s headquarters in Seoul, South Korea. Transaction follows the June 2021...
- Neurosigma, Inc.
- Colin P. Kealey, M.D
- Ian A. Cook, M.D.
- Charles W. Winckler
- Vikas Gupta
- Patrick Miller
President & CEO
Dr. Kealey has served as NeuroSigma's CEO since January of 2022. Dr. Kealey has been with NeuroSigma since 2011, having previously served as our President, Vice President of Advanced Development and Medical Affairs, and Manager of Business Development. In these roles, Dr. Kealey spearheaded NeuroSigma's regulatory submissions that ultimately led to FDA clearance of the Monarch eTNS System for pediatric ADHD. He also helped introduce eTNS to major academic centers and clinics throughout the Un...
SENIOR VICE-PRESIDENT AND CHIEF MEDICAL OFFICER
Dr. Cook has been our Chief Medical Officer and Senior Vice President since January 2014, previously having served as a medical advisor to the Company since 2009. An inventor of trigeminal nerve stimulation, he brings a track record of innovation in the use of technology in the management of brain disorders as well as of translational research in treatment development. Formerly the Miller Professor of Psychiatry and of Bioengineering at UCLA, he received years of NIH and industry research sup...
Chief Financial Officer
Mr. Winckler brings over 18 years of industry experience in venture backed technology companies. Prior to his current role at NeuroSigma, Mr. Winckler held the position of CFO, and he has recently held the position of CFO and/or Senior Financial Advisor at US Seismic Systems, Inc., PBS Biotech, Inc., DevZuz Holdings, Inc.; Greenplum, Inc.; Vativ Technologies, Inc.; Litex, Inc.; and Sabeus, Inc. In addition, Mr. Winckler has represented start-up companies in various mergers and acquisitions de...
Director of Engineering
Mr. Gupta has served as NeuroSigma’s Director of Engineering since April 2015. Prior to working with NeuroSigma, he founded SelfEx Solutions, a Nitinol medical device consultancy that provided engineering services to start-ups for the design and development of Nitinol-based medical devices. Specifically, he provided their engineering teams guidance on the selection of materials, the design and processing of Nitinol-based medical devices, and on prototyping and development of the fully-assembl...
Director of Operations
Mr. Miller has served as Clinical Research Administrator for clinical trials conducted at the University of California, Los Angeles exploring therapies for epilepsy and depression. He has worked closely with Drs. Christopher DeGiorgio and Ian Cook in the development of Trigeminal Nerve Stimulation (TNS) and, in collaboration with Dr. DeGiorgio, has helped develop new tools and biomarkers for determining the risk in Sudden Unexplained Death in Epilepsy (SUDEP). Mr. Miller received a BS in Elec...
Jan 18, 2024 · “FDA clearance of Monarch 2.0 is a major commercial and strategic milestone for NeuroSigma, and we look forward to further progress in 2024,” said C. Thomas Paschall, Director of NeuroSigma and...
- Neurosigma, Inc.
Dec 8, 2021 · Signing Ceremony KT Senior EVP and Head of AI/DX Jae-ho Song and NeuroSigma Director, C. Thomas Paschall execute inve...
- Neurosigma, Inc.
Jan 26, 2022 · C. Thomas Paschall, Director of NeuroSigma and CEO of Checkmate Capital, commented, “This transaction is a significant cross-border achievement.
Mar 26, 2014 · Coronal Management, LLC , an alternative energy firm that develops, finances, builds operates and maintains solar photovoltaic projects, announced that C. Thomas Paschall, a specialist in...
